Ckd Bio (063160) — Cash Flow Reinvestment Rate

Latest as of March 2026: 4.87x

Ckd Bio (063160) has a Cash Flow Reinvestment Rate of 4.87x as of March 2026, reinvesting ₩3.76 Billion (capex ₩3.66 Billion plus investments ₩-100.00 Million) from operating cash flow of ₩771.88 Million. Check Ckd Bio (063160) cash earnings ratio to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

4.87x
(Capex + Investments) / Operating CF

Total Reinvested

₩3.76 Billion
Capex + Investments

Operating Cash Flow

₩771.88 Million
KRW

Capital Expenditures

₩3.66 Billion
KRW

Ckd Bio Cash Flow Reinvestment Rate (2008–2024)

Historical reinvestment intensity for Ckd Bio across 14 annual periods. Explore Ckd Bio (063160) long-term investment share to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Ckd Bio (2008–2024)

Year-by-year capital reinvestment analysis for Ckd Bio. For live market cap and broader valuation context, see market value of Ckd Bio.

Year Reinvestment Rate Total Reinvested (KRW) Operating CF Capex YoY Change
2024 0.64x ₩9.04 Billion ₩14.03 Billion ₩4.28 Billion ▼ -95.0%
2020 12.78x ₩61.66 Billion ₩4.82 Billion ₩61.66 Billion ▲ +316.7%
2019 3.07x ₩52.12 Billion ₩16.99 Billion ₩47.31 Billion ▲ +173.3%
2018 1.12x ₩17.44 Billion ₩15.54 Billion ₩16.40 Billion ▲ +2.8%
2017 1.09x ₩22.32 Billion ₩20.45 Billion ₩9.67 Billion ▼ -22.6%
2016 1.41x ₩21.86 Billion ₩15.50 Billion ₩10.76 Billion ▲ +68.8%
2015 0.84x ₩11.98 Billion ₩14.34 Billion ₩11.91 Billion ▲ +174.2%
2014 0.30x ₩3.42 Billion ₩11.22 Billion ₩2.87 Billion ▼ -28.4%
2013 0.43x ₩4.65 Billion ₩10.92 Billion ₩4.10 Billion ▲ +30.8%
2012 0.33x ₩7.45 Billion ₩22.90 Billion ₩5.48 Billion ▼ -81.4%
2011 1.75x ₩22.68 Billion ₩12.96 Billion ₩22.09 Billion ▲ +106.3%
2010 0.85x ₩20.26 Billion ₩23.89 Billion ₩19.74 Billion ▲ +64.2%
2009 0.52x ₩13.72 Billion ₩26.57 Billion ₩13.53 Billion ▼ -25.5%
2008 0.69x ₩7.41 Billion ₩10.69 Billion ₩3.47 Billion —
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow